Epcoritamab Plus Gemcitabine and Oxaliplatin Versus Rituximab Plus Gemcitabine and Oxaliplatin in Transplant-Ineligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Match-Adjusted Comparative Analysis. - Munoz J; Rosenthal A; Ip A; Darrah JM; Wang T; Zhang G; Mutebi A; Branchcomb T; Ding Z; Chhibber A; Navarro FR; Risum M; et al. (Clinical lymphoma, myeloma & leukemia, 2026)